This Was a Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines
Clinical trial NCT03926611 · COMPLETED
Trial details
- NCT number
- NCT03926611
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-06
- Primary completion
- 2021-01-14
- Enrollment
- 311
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.